Omni Health Inc (OMHE)

[lesgetrich]

Alternative (fake) facts!

OK Let's take them one by one...

1.)

OMHE has continued operational losses.

From the last 10-Q financials...



The pro-forma statement which filters out the numbers from the old VitaCig product line shows a net operational profit of $593,858 thru the first nine months of the fiscal year

2.)

OMHE is diluting

This is just total fantasy which contradicts reality. From the last PR...

Andrey Soloviev, the company's Chief Executive Officer and Chairman of the Board has converted 556,890,449 shares of common stock into 5,600,000 Series A Preferred Stock. In addition, 50,000,000 shares of common stock are to be converted into 5,000,000 shares of Series B Preferred Stock by several large shareholders. The actions reduce the outstanding common stock of OMHE by 62% to 368,938,292 shares of common stock.

Mr. Soloviev stated, "Recognizing the continued evolution of our anti-aging cream business, and our strategy to grow and enter into the cannabis and biotech platforms, we conducted a thorough review of our corporate structure to optimize our support of both existing and future operations." He went on to say, "This conversion of common stock to preferred stock benefits our shareholders. This allows our shareholders the ability to look into the future without concern of dilution from these shares being available to be sold into the market."

They're not diluting. They're doing just the opposite.

3.)

OMHE is incurring more debt

Again from the 10-Q...



Omni took out $ 2,256,987 in loans last year, As of 1/31/17 the remaining balance was $ 1,446,528.

They've actually reduced their debt by $810,459 within the past year.

4.)

OMHE is paying its insiders handsomely; as evidenced by recent conversion of common shares to preferred shares; which benefit insiders much, much more vs. omhe common shareholders.

Preferred shares didn't exist until last week. Conversion of common shares to preferred shares takes those shares out of the OS and the real benefit goes to the rest of us as the book value of our shares increases proportionately. The conversions are value neutral to the new owners and their only benefit is voting rights which they already control anyway.

5.)

In addition, there's NOTHING THAT PREVENTS OMHE FROM ISSUING NEW SHARES OR TAKE ON MORE DEBT TO FINANCE "ACQUISITIONS"

LMAO This is true of every public company not just OMHE. If they do acquire another company, it could just as easily be antidilutive (the exact opposite of dilutive). From Investopedia...

Definition of "antidilutive"

Although most commonly used in reference to convertible securities whose exercise would have the effect of increasing EPS, the use of the term "antidilutive" has become much more comprehensive.

For example, if Company A acquires Company B by using its common stock, but the earnings of Company B add more to EPS than the common stock issued, it is said to be an antidilutive acquisition.

Debunked 5 times! ROTFLMAO